229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.13%
Revenue growth under 50% of VUZI's 37.54%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
1.75%
Gross profit growth under 50% of VUZI's 47.39%. Michael Burry would be concerned about a severe competitive disadvantage.
0.30%
EBIT growth below 50% of VUZI's 16.82%. Michael Burry would suspect deeper competitive or cost structure issues.
0.30%
Operating income growth under 50% of VUZI's 16.82%. Michael Burry would be concerned about deeper cost or sales issues.
1.99%
Net income growth under 50% of VUZI's 17.57%. Michael Burry would suspect the firm is falling well behind a key competitor.
1.66%
EPS growth under 50% of VUZI's 17.14%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
1.26%
Diluted EPS growth under 50% of VUZI's 17.14%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.28%
Share change of 0.28% while VUZI is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.68%
Diluted share change of 0.68% while VUZI is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
169.92%
Positive OCF growth while VUZI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
175.59%
Positive FCF growth while VUZI is negative. John Neff would see a strong competitive edge in net cash generation.
245.01%
10Y revenue/share CAGR above 1.5x VUZI's 13.63%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
247.41%
5Y revenue/share CAGR above 1.5x VUZI's 13.63%. David Dodd would look for consistent product or market expansions fueling outperformance.
81.74%
3Y revenue/share CAGR above 1.5x VUZI's 13.63%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
1563.14%
10Y OCF/share CAGR above 1.5x VUZI's 80.04%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
802.89%
5Y OCF/share CAGR above 1.5x VUZI's 80.04%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
114.74%
3Y OCF/share CAGR 1.25-1.5x VUZI's 80.04%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
290.34%
Net income/share CAGR above 1.5x VUZI's 35.48% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
1590.88%
5Y net income/share CAGR above 1.5x VUZI's 35.48%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
148.05%
3Y net income/share CAGR above 1.5x VUZI's 35.48%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
461.99%
Positive growth while VUZI is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
351.51%
Positive 5Y equity/share CAGR while VUZI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
164.33%
Positive short-term equity growth while VUZI is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
37.68%
AR growth of 37.68% while VUZI is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
21.79%
Inventory growth of 21.79% while VUZI is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
11.34%
Asset growth of 11.34% while VUZI is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
6.19%
BV/share growth of 6.19% while VUZI is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
No Data
No Data available this quarter, please select a different quarter.
6.90%
R&D dropping or stable vs. VUZI's 50.48%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
2.54%
SG&A growth well above VUZI's 0.41%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.
